» Articles » PMID: 9009275

Cyclosporin A-sensitive Induction of the Epstein-Barr Virus Lytic Switch is Mediated Via a Novel Pathway Involving a MEF2 Family Member

Overview
Journal EMBO J
Date 1997 Jan 2
PMID 9009275
Citations 65
Authors
Affiliations
Soon will be listed here.
Abstract

Induction of the Epstein-Barr virus (EBV) lytic cycle by crosslinking surface immunoglobulin is inhibited by the immunosuppressants cyclosporin A (CsA) and FK506. This correlates with the ability of CsA to inhibit Ca2+-dependent transcription of the lytic cycle switch gene BZLF1. It is shown here that CsA sensitivity maps to three sites (ZIA, ZIB and ZID) that bind the serum response factor-related protein MEF2D. A synthetic promoter containing multiple copies of a MEF2D site from Zp, in conjunction with a CREB/AP-1 site (ZII) from Zp, exhibits CsA-sensitive inducibility. Furthermore, the Zp MEF2D sites were functionally interchangeable with MEF2 sites derived from heterologous promoters. While no evidence of a NFAT family member binding to either the MEF2 or CREB/AP-1 sites was obtained, it could be demonstrated that CsA-sensitive induction of Zp was mediated by calcineurin and NFATc2 in synergy with either phorbol ester or especially with the EBV-induced Ca2+/calmodulin-dependent kinase type IV/Gr. These studies identify Zp as prototypic of a novel class of CsA-sensitive and NFAT-dependent promoters defined by the presence of MEF2 sites.

Citing Articles

A distinct isoform of lymphoid enhancer binding factor 1 (LEF1) epigenetically restricts EBV reactivation to maintain viral latency.

Ward B, Prasai K, Schaal D, Wang J, Scott R PLoS Pathog. 2023; 19(12):e1011873.

PMID: 38113273 PMC: 10763950. DOI: 10.1371/journal.ppat.1011873.


How Does Epstein-Barr Virus Interact With Other Microbiomes in EBV-Driven Cancers?.

Wen Y, Xu H, Han J, Jin R, Chen H Front Cell Infect Microbiol. 2022; 12:852066.

PMID: 35281433 PMC: 8904896. DOI: 10.3389/fcimb.2022.852066.


Molecular Basis of Epstein-Barr Virus Latency Establishment and Lytic Reactivation.

Murata T, Sugimoto A, Inagaki T, Yanagi Y, Watanabe T, Sato Y Viruses. 2021; 13(12).

PMID: 34960613 PMC: 8706188. DOI: 10.3390/v13122344.


Andrographolide Inhibits Lytic Reactivation of Epstein-Barr Virus by Modulating Transcription Factors in Gastric Cancer.

Malat P, Ekalaksananan T, Heawchaiyaphum C, Suebsasana S, Roytrakul S, Yingchutrakul Y Microorganisms. 2021; 9(12).

PMID: 34946164 PMC: 8708910. DOI: 10.3390/microorganisms9122561.


B Cell Receptor-Responsive miR-141 Enhances Epstein-Barr Virus Lytic Cycle via FOXO3 Inhibition.

Chen Y, Fachko D, Ivanov N, Skalsky R mSphere. 2021; 6(2).

PMID: 33853871 PMC: 8546685. DOI: 10.1128/mSphere.00093-21.


References
1.
Hardwick J, Lieberman P, Hayward S . A new Epstein-Barr virus transactivator, R, induces expression of a cytoplasmic early antigen. J Virol. 1988; 62(7):2274-84. PMC: 253372. DOI: 10.1128/JVI.62.7.2274-2284.1988. View

2.
Miller G, RABSON M, Heston L . Epstein-Barr virus with heterogeneous DNA disrupts latency. J Virol. 1984; 50(1):174-82. PMC: 255597. DOI: 10.1128/JVI.50.1.174-182.1984. View

3.
Farrell P, Rowe D, Rooney C, Kouzarides T . Epstein-Barr virus BZLF1 trans-activator specifically binds to a consensus AP-1 site and is related to c-fos. EMBO J. 1989; 8(1):127-32. PMC: 400780. DOI: 10.1002/j.1460-2075.1989.tb03356.x. View

4.
Flemington E, Speck S . Identification of phorbol ester response elements in the promoter of Epstein-Barr virus putative lytic switch gene BZLF1. J Virol. 1990; 64(3):1217-26. PMC: 249236. DOI: 10.1128/JVI.64.3.1217-1226.1990. View

5.
Flemington E, Speck S . Autoregulation of Epstein-Barr virus putative lytic switch gene BZLF1. J Virol. 1990; 64(3):1227-32. PMC: 249237. DOI: 10.1128/JVI.64.3.1227-1232.1990. View